Director

Kevin Conroy

Director·Abbott Laboratories

About

Kevin Conroy was named to the Abbott Laboratories Board of Directors on April 24, 2026. His appointment was reported in Abbott's Form 8-K filed April 27, 2026; no additional biographical information is provided in the source filings.

Since 2026

Also at Abbott Laboratories

NM Nita Ahuja, M.D. Director RM Robert J. Alpern, M.D. Director CB Claire Babineaux-Fontenot Director SP Sally E. Blount, Ph.D. Director RF Robert B. Ford Chairman of the Board and Chief Executive Officer; Director PG Paola Gonzalez Director

Roles

Organization Role Dates Details
Abbott Laboratories Director 2026–present Current role
Exact Sciences Corporation Chairman, President and Chief Executive Officer March 2014 to March 2026 Remained with the company in an advisory role following Abbott's acquisition of Exact Sciences.
Exact Sciences Corporation President and Chief Executive Officer 2009 to 2014
Third Wave Technologies, Inc. President and Chief Executive Officer 2005 to 2008

External roles

Organization Role Dates
Align Technology, Inc. Board of Directors member
Adaptive Biotechnologies Corporation Board of Directors member 2019 to 2023
Epizyme, Inc. Board of Directors member 2017 to 2022
CM Life Sciences II Inc. Board of Directors member 2021
SomaLogic, Inc. Board of Directors member 2021

Related

Source: Abbott Laboratories SEC filings and official company website

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo